These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8119151)

  • 41. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.
    Li Q; Brownfield MS; Levy AD; Battaglia G; Cabrera TM; Van de Kar LD
    Biol Psychiatry; 1994 Sep; 36(5):300-8. PubMed ID: 7993956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations.
    Bagdy G; Kalogeras KT; Szemeredi K
    Eur J Pharmacol; 1992 Dec; 229(1):9-14. PubMed ID: 1473565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GABAergic mediation of stress-induced secretion of corticosterone and oxytocin, but not prolactin, by the hypothalamic paraventricular nucleus.
    Marques de Souza L; Franci CR
    Life Sci; 2008 Nov; 83(19-20):686-92. PubMed ID: 18840449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.
    Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA
    J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of selective serotonin receptor agonists on prolactin secretion in male rats.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1993 Mar; 57(3):401-7. PubMed ID: 8321411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor.
    Grignaschi G; Sironi F; Samanin R
    Brain Res; 1996 Feb; 708(1-2):173-6. PubMed ID: 8720874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear.
    Rittenhouse PA; Bakkum EA; O'Connor PA; Carnes M; Bethea CL; van de Kar LD
    Brain Res; 1992 May; 580(1-2):205-14. PubMed ID: 1354556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats.
    Aulakh CS; Mazzola-Pomietto P; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1994 Oct; 271(1):143-8. PubMed ID: 7965707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat.
    Alper RH
    Neuroendocrinology; 1990 Mar; 51(3):255-60. PubMed ID: 2109269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation.
    Di Sciullo A; Bluet-Pajot MT; Mounier F; Oliver C; Schmidt B; Kordon C
    Endocrinology; 1990 Aug; 127(2):567-72. PubMed ID: 2164913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion.
    Van de Kar LD; Carnes M; Maslowski RJ; Bonadonna AM; Rittenhouse PA; Kunimoto K; Piechowski RA; Bethea CL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):428-34. PubMed ID: 2553918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
    Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
    Li Q; Brownfield MS; Battaglia G; Cabrera TM; Levy AD; Rittenhouse PA; van de Kar LD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):836-44. PubMed ID: 8394920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasopressin administration into the paraventricular nucleus normalizes plasma oxytocin and corticosterone levels in Brattleboro rats.
    Zelena D; Langnaese K; Domokos A; Pintér O; Landgraf R; Makara GB; Engelmann M
    Endocrinology; 2009 Jun; 150(6):2791-8. PubMed ID: 19246538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.